Advances in nanotechnology have favored the development of novel colloidal formulations
able to modulate the pharmacological and biopharmaceutical properties of drugs. The …

With the emerging advances in utilizing nanocarriers for biomedical applications, a
molecular-level understanding of the in vivo fate of nanocarriers is necessary. After …

Effective delivery of therapeutic and diagnostic nanoparticles is dependent on their ability to
accumulate in diseased tissues. However, most nanoparticles end up in liver macrophages …

Engineering nanomaterials are increasingly considered promising and powerful biomedical
tools or devices for imaging, drug delivery, and cancer therapies, but few nanomaterials …

As an emerging pollutant in the life cycle of plastic products, micro/nanoplastics (M/NPs) are
increasingly being released into the natural environment. Substantial concerns have been …

Treatment of neurodegenerative diseases or other central nervous system (CNS) disorders
has always been a significant challenge. The nature of the blood-brain barrier (BBB) limits …

When in contact with biological fluids, nanoparticles dynamically absorb biomolecules like
proteins and lipids onto their surface, forming a “corona”. This biocorona is a dynamic and …

DNA-functionalized gold nanoparticles (AuNPs) are popular hybrid materials with
applications in directed assembly, biosensor development, and drug delivery. This system is …

Robust characterization of the protein corona—the layer of proteins that spontaneously
forms on the surface of nanoparticles immersed in biological fluids—is vital for prediction of …

Lipid nanoparticle SNAs (LNP-SNAs) have been synthesized for the delivery of DNA and
RNA to targets in the cytoplasm of cells. Both the composition of the LNP core and surface …